Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tumour necrosis factor alpha downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula.

Literature DB >> 16531548

Tumour necrosis factor alpha downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula.

C Hassan, A Zullo, E Ierardi, O Burattini, V De Francesco, S Morini.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2006 PMID： 16531548 PMCID： PMC1856166 DOI： 10.1136/gut.2005.084756

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

8 in total

Review 1. Biologics in inflammatory bowel disease: how much progress have we made?

Authors: W J Sandborn; W A Faubion
Journal: Gut Date: 2004-09 Impact factor: 23.059

2. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.

Authors: F J Baert; G R D'Haens; M Peeters; M I Hiele; T F Schaible; D Shealy; K Geboes; P J Rutgeerts
Journal: Gastroenterology Date: 1999-01 Impact factor: 22.682

3. Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease.

Authors: S H Murch; C P Braegger; J A Walker-Smith; T T MacDonald
Journal: Gut Date: 1993-12 Impact factor: 23.059

4. Helicobacter heilmannii gastritis: a histological and immunohistochemical trait.

Authors: E Ierardi; R A Monno; A Gentile; R Francavilla; O Burattini; S Marangi; L Pollice; A Francavilla
Journal: J Clin Pathol Date: 2001-10 Impact factor: 3.411

5. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

Authors: Gunnar Järnerot; Erik Hertervig; Ingalill Friis-Liby; Lars Blomquist; Per Karlén; Christer Grännö; Mogens Vilien; Magnus Ström; Ake Danielsson; Hans Verbaan; Per M Hellström; Anders Magnuson; Bengt Curman
Journal: Gastroenterology Date: 2005-06 Impact factor: 22.682

6. Segmental colitis associated with diverticula: a prospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII).

Authors: G Imperiali; G Meucci; C Alvisi; R Fasoli; A Ferrara; C M Girelli; F Rocca; S Saibeni; G Minoli
Journal: Am J Gastroenterol Date: 2000-04 Impact factor: 10.864

7. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.

Authors: H C Reinecker; M Steffen; T Witthoeft; I Pflueger; S Schreiber; R P MacDermott; A Raedler
Journal: Clin Exp Immunol Date: 1993-10 Impact factor: 4.330

8. The spectrum of segmental colitis associated with diverticulosis.

Authors: I E Koutroubakis; P Antoniou; M Tzardi; E A Kouroumalis
Journal: Int J Colorectal Dis Date: 2004-08-14 Impact factor: 2.571

8 in total

Review 1. Segmental colitis associated with diverticulosis: complication of diverticular disease or autonomous entity?

Authors: Antonio Tursi
Journal: Dig Dis Sci Date: 2010-04-22 Impact factor: 3.199

Review 2. Management of Diverticular Disease in the Setting of Other Colorectal Pathology: Data on Simultaneous Issues in Segmental Colitis, Inflammatory Bowel Disease, Cancer, and Complications.

Authors: Nasrin Ghalyaie
Journal: Clin Colon Rectal Surg Date: 2018-06-22

Review 3. Considerations and Changes in the Evaluation, Management, and Outcomes in the Management of Diverticular Disease: The Diagnosis, Pathology, and Treatment of Diverticular Colitis.

Authors: Robert J Kucejko; Juan L Poggio
Journal: Clin Colon Rectal Surg Date: 2018-06-22

4. A case of diverticular colitis with lesions resembling ulcerative colitis and correlation of tumor necrosis factor-alpha staining with clinical manifestations.

Authors: Yoshinori Torii; Yoshiaki Katano; Junji Yoshino; Kazuo Inui; Takao Wakabayasi; Takashi Kobayashi; Toshihito Kosaka
Journal: Clin J Gastroenterol Date: 2015-12

Review 8. Segmental colitis associated with diverticulosis: is it the coexistence of colonic diverticulosis and inflammatory bowel disease?

Authors: John Schembri; John Bonello; Dimitrios K Christodoulou; Konstantinos H Katsanos; Pierre Ellul
Journal: Ann Gastroenterol Date: 2017-01-31

8 in total

Tumour necrosis factor alpha downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula.

Review 1. Biologics in inflammatory bowel disease: how much progress have we made?

2. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.

3. Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease.

4. Helicobacter heilmannii gastritis: a histological and immunohistochemical trait.

5. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

6. Segmental colitis associated with diverticula: a prospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII).

7. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.

8. The spectrum of segmental colitis associated with diverticulosis.

Review 1. Segmental colitis associated with diverticulosis: complication of diverticular disease or autonomous entity?

Review 2. Management of Diverticular Disease in the Setting of Other Colorectal Pathology: Data on Simultaneous Issues in Segmental Colitis, Inflammatory Bowel Disease, Cancer, and Complications.

Review 3. Considerations and Changes in the Evaluation, Management, and Outcomes in the Management of Diverticular Disease: The Diagnosis, Pathology, and Treatment of Diverticular Colitis.

4. A case of diverticular colitis with lesions resembling ulcerative colitis and correlation of tumor necrosis factor-alpha staining with clinical manifestations.

5. Segmental colitis associated with diverticulosis: a 5-year follow-up.

Review 6. Features and management of colonic diverticular disease.

7. Tumour necrosis factor alpha in segmental colitis associated with diverticula.

Review 8. Segmental colitis associated with diverticulosis: is it the coexistence of colonic diverticulosis and inflammatory bowel disease?